PMID- 32832453
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20200928
IS  - 2229-5178 (Print)
IS  - 2249-5673 (Electronic)
IS  - 2229-5178 (Linking)
VI  - 11
IP  - 4
DP  - 2020 Jul-Aug
TI  - Complete Remission in a Patient with Treatment Refractory Bullous Pemphigoid 
      after a Single Dose of Omalizumab.
PG  - 607-611
LID - 10.4103/idoj.IDOJ_438_19 [doi]
AB  - Bullous pemphigoid (BP) is an autoimmune disorder known to be mediated by 
      immunoglobulin G (IgG) autoantibodies. The role of immunoglobulin E (IgE) 
      antibodies is being investigated as their presence has been described in severe 
      cases. Herein, we report a patient of BP who was refractory to most conventional 
      agents and developed hypotension after rituximab but achieved lasting remission 
      after a single dose of the anti-IgE monoclonal antibody omalizumab.
CI  - Copyright: (c) 2020 Indian Dermatology Online Journal.
FAU - Sinha, Surabhi
AU  - Sinha S
AD  - Department of Dermatology, Venereology and Leprology, Dr. RML Hospital and 
      PGIMER, New Delhi, India.
FAU - Agrawal, Diksha
AU  - Agrawal D
AD  - Department of Dermatology, Venereology and Leprology, Dr. RML Hospital and 
      PGIMER, New Delhi, India.
FAU - Sardana, Kabir
AU  - Sardana K
AD  - Department of Dermatology, Venereology and Leprology, Dr. RML Hospital and 
      PGIMER, New Delhi, India.
FAU - Kulhari, Anita
AU  - Kulhari A
AD  - Department of Dermatology, Venereology and Leprology, Dr. RML Hospital and 
      PGIMER, New Delhi, India.
FAU - Malhotra, Purnima
AU  - Malhotra P
AD  - Department of Pathology, Dr. RML Hospital and PGIMER, New Delhi, India.
LA  - eng
PT  - Case Reports
DEP - 20200713
PL  - India
TA  - Indian Dermatol Online J
JT  - Indian dermatology online journal
JID - 101586880
PMC - PMC7413437
OTO - NOTNLM
OT  - Bullous pemphigoid
OT  - immunoglobulin E
OT  - omalizumab
OT  - refractory
COIS- There are no conflicts of interest.
EDAT- 2020/08/25 06:00
MHDA- 2020/08/25 06:01
PMCR- 2020/07/13
CRDT- 2020/08/25 06:00
PHST- 2019/09/02 00:00 [received]
PHST- 2019/09/27 00:00 [revised]
PHST- 2019/11/12 00:00 [accepted]
PHST- 2020/08/25 06:00 [entrez]
PHST- 2020/08/25 06:00 [pubmed]
PHST- 2020/08/25 06:01 [medline]
PHST- 2020/07/13 00:00 [pmc-release]
AID - IDOJ-11-607 [pii]
AID - 10.4103/idoj.IDOJ_438_19 [doi]
PST - epublish
SO  - Indian Dermatol Online J. 2020 Jul 13;11(4):607-611. doi: 
      10.4103/idoj.IDOJ_438_19. eCollection 2020 Jul-Aug.